HEALTHSTREAM INC
HSTMdata completeness 88%17 fiscal years on fileData notes: no data for concept 'totalDebt'; no data for concept 'interestExpense'
HEALTHSTREAM INC earns about 5% on invested capital, below its ~9% cost of capital, and has bought back 5% of its shares over 5 years — no moat visible in the numbers. The estimate methods put fair value between $5.23 and $83.87 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $256.7M1 | $266.8M2 | $279.1M3 | $291.6M3 | $304.1M3 |
| Net income | $5.85M4 | $12.1M5 | $15.2M6 | $20M6 | $18.3M6 |
| Operating cash flow | $42.4M7 | $51.2M8 | $64M9 | $57.7M9 | $63.3M9 |
| Capital expenditure | $3.42M10 | $1.77M11 | $2.2M12 | $1.4M12 | $3.69M12 |
| Free cash flow (derived) | $39M7 | $49.4M8 | $61.8M9 | $56.3M9 | $59.6M9 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $46.9M13 | $46M14 | $40.3M15 | $59.5M16 | $36.2M16 |
| Diluted shares | 31.6M | 30.7M | 30.7M | 30.5M | 30.1M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $117.44 of net worth that earned you $6.08 and generated $19.78 of cash last year.
It earned about 5% on invested capital against a ~9% cost of capital — below the cost of funding. The numbers show no moat.
seeing a moat in the numbers →Share count is down 5% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
The 3 estimate methods that apply put fair value between $5.23 and $83.87 a share. They rest on different assumptions, so where they diverge is the story; the Graham Number is a stricter floor, not a target.
assumptions (10)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears10
- fcfGrowth15.2%
- fcfBase$59.6M
assumptions (10)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears5
- fcfGrowth15.2%
- fcfBase$59.6M
assumptions (8)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$15.2M
- growthAssumed0.0%
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
| Bear | 0.0% | $29.47 |
| Base | 15.2% | $54.72 |
| Bull | 20.0% | $65.7 |
Bear/base/bull growth = 0% / filed history / history + 5pp. Type a price to see the return each case implies.
Default growth 15.2%= this company’s own filed history (median-to-median FCF CAGR, clamped 0–20%). Your adjustments are recorded anonymously. They become the “what do owners actually believe” dataset.
- 10-K · period ending 2021-12-31 · accession 0001437749-24-005530 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001437749-25-005705 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001437749-26-005916 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001437749-24-005530 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001437749-25-005705 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001437749-26-005916 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001437749-24-005530 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001437749-25-005705 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001437749-26-005916 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001437749-24-005530 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0001437749-25-005705 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-31 · accession 0001437749-26-005916 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001437749-23-004908 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001437749-24-005530 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-005705 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001437749-26-005916 (CashAndCashEquivalentsAtCarryingValue)